THCX News and Press, Spinnaker ETF Series The Cannabis From 02/27/22

In November, 2021 AdvisorShares partnered with Poseidon Asset Management and launched the Poseidon Dynamic Cannabis ETF (PSDN). The fund is differentiated by the deep and proven management team, flexible mandate, and the ability to leverage the portfolio up to 1.5x. PSDN is best s...

Top Marijuana ETFs In January 2022 Are you looking for top marijuana stocks to buy before February 2022? In January many of the best cannabis stocks to invest in have established new lows to start the year. In general, this is mostly related to delays with federal marijuana legali...

Best Cannabis ETFs For Your 2022 Watchlist Are you looking for the best marijuana stocks to buy for 2022? For many new cannabis investors, this may be difficult with the amount of different top cannabis stocks to invest in. In 2021 the cannabis sector sustained significant losses du...

Investing In The Cannabis Sector Right Now Are you looking for the best marijuana stocks to invest in for 2022? In December the cannabis sector has declined to some of the lowest market value seen in 2021. This is mostly due to the delays with federal cannabis reform and the Senate&...

Edifying episode with industry expert Brady Cobb. Recent cannabis legislation; moving from optics to real reform. SAFE Banking, uplisting and what it all means for cannabis investors. MSOs, ETFs new and old, future valuations, Florida and NY/NJ markets. Selling to Cresco, focu...

Banking Reform will not be included in Defense Spending Bill after Congress added provisions this fall. We continue to believe late 2022 is earliest realistic timeframe for initial federal legislation including banking. Expect stock returns and valuations to remain pressured in th...

Announced acquisition of New Mexico’s 2nd largest operator. Additionally announced a $95M financing to fund transaction and other M&A opportunities. New Mexico to be a high growth state in ’22 as rec sales commence in late March at the latest. Schwazze now we...

It's an appropriate time to take stock of the developments in the cannabis industry. One year in cannabis can feel like several given the many ups and downs that take place in a 12 month span. 2021 delivered a mixed bag of wins and losses. For further details see: 2021 -...

Jon DeCourcey, formerly of Canaccord now with Viridian Capital Advisors, joins us to discuss recent cannabis earnings and why he favors mid-tier multi-state operators (MSOs) over the Big 5. SAFE Banking expectations, how he sees valuations growing. Why retail investors should be e...

GAGE growing with retail and cultivation assets in MI. TerrAscend deal poised to close in early ’22. Reduce rating to hold and price target to $1.91 reflecting TerrAscend deal. Potential for upside in short term on TerrAscend stock gains on legislative news or additiona...